Bayer's overall financial performance: Bayer's revenues, profits, and debt levels significantly impact investor confidence and, consequently, BDUUY's price.

Success of Bayer's pharmaceutical division: Developments in their drug pipeline, regulatory approvals, and market performance of key drugs all influence stock value.

Performance of Crop Science division: Sales of agricultural products, seed innovations, and glyphosate-related issues (legal and market) play a crucial role.

Legal liabilities related to glyphosate: Ongoing Roundup litigation and settlements can heavily affect investor sentiment and share price.

Overall market conditions: Broad economic trends, investor sentiment, and global market performance can influence BDUUY along with other stocks.

Currency exchange rates: Fluctuations between the Euro (Bayer is a German company) and the US Dollar affect the value of BDUUY.

Investor perception and analyst ratings: How investors view Bayer's prospects and analysts' recommendations can drive buying or selling pressure.

Competitor performance: The success or failure of Bayer's competitors in pharmaceuticals and agriculture can impact its relative attractiveness to investors.

Changes in regulations: Shifts in environmental or pharmaceutical regulations can affect Bayer's business operations and profitability.

Dividend policy: Changes to Bayer's dividend payouts can influence investor demand for the stock.